Tomohiko Sunami, Atsushi Yamada, Tomohiro Kondo, Masashi Kanai, Kazuyuki Nagai, Yoichiro Uchida, Masataka Yokode, Tomoaki Matsumori, Norimitsu Uza, Hiromi Murakami, Takahiro Yamada, Manabu Muto.

Exceptional Response of Pancreatic Acinar Cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a Germline BRCA2 Variant.

Pancreas. 2022 Oct 1;51(9):1258-1262.

Yu Uneno, Haruki Imura, Yosuke Makuuchi, Kentaro Tochitani and Norio Watanabe.

Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer.

Cochrane Database Syst Rev. 2022 Nov 28;11(11):CD013604.

Soichiro Okamoto, Yu Uneno, Natsuki Kawashima, Shunsuke Oyamada, Yusuke Hiratsuka, Keita Tagami, Manabu Muto, Tatsuya Morita.

Difficulties facing junior physicians and solutions toward delivering end-of-life care for patients with cancer: a nationwide survey in Japan.

Palliat Med Rep. 2022 Oct 27;3(1):255-263.

Tomoyuki Abe, Yoshihito Horisawa, Osamu Kikuchi, Hitomi Ozawa-Umeta, Atsuhiro Kishimoto, Yasuhiro Katsuura, Atsushi Imaizumi, Tadashi Hashimoto, Kotaro Shirakawa, Akifumi Takaori-Kondo, Kosuke Yusa, Tadashi Asakura, Hideaki Kakeya, Masashi Kanai.

Pharmacologic characterization of TBP1901, a prodrug form of aglycone curcumin, and CRISPR-Cas9 screen for therapeutic targets of aglycone curcumin.

Eur J Pharmacol. 2022 Nov 15;935:175321.

Yoshihiro Yamamoto Keita Fukuyama, Masashi Kanai, Tomohiro Kondo, Masahiro Yoshioka, Tadayuki Kou, Pham Nguyen Quy, Reiko Kimura-Tsuchiya, Takahiro Yamada, Shigemi Matsumoto, Shinji Kosugi, Manabu Muto.

Prevalence of pathogenic germline variants in the circulating tumor DNA testing.

Int J Clin Oncol. 2022 Oct;27(10):1554-1561.

Atsushi Yamada, Yoshihiro Yamamoto, Sachiko Minamiguchi, Mayumi Kamada, Tomohiko Sunami, Shinya Ohashi, Hiroshi Seno, Kenji Kawada, Manabu Muto.

Clinicopathological and molecular characterization of deficient mismatch repair colorectal cancer.

Hum Pathol. 2022 Sep 21;130:1-9.

Yoshinobu Yamamoto,Naohiro Yoshida,Tomonori Yano,Takahiro Horimatsu,Noriya Uedo ,Noboru Kawata,Hiromitsu Kanzaki,Shinichiro Hori,Kenshi Yao,Seiichiro Abe,Chikatoshi Katada,Chizu Yokoi,Ken Ohata,Hisashi Doyama,Kenichi Yoshimura,Hideki Ishikawa,Manabu Muto.

Assessment of Outcomes From 1-Year Surveillance After Detection of Early Gastric Cancer Among Patients at High Risk in Japan.

JAMA Netw Open. 2022 Aug 1;5(8):e2227667.

Uneno Y, Iwai M, Morikawa N, Tagami K, Matsumoto Y, Nozato J, Kessoku T, Shimoi T, Yoshida M, Miyoshi A, Sugiyama I, Mantani K, Itagaki M, Yamagishi A, Morita T, Inoue A, Muto M.

Development of a national health policy logic model to accelerate the integration of oncology and palliative care: a nationwide Delphi survey in Japan.

Int J Clin Oncol. 2022 Sep;27(9):1529-1542.

Yosuke Mitani,Shinya Ohashi,Osamu Kikuchi,Yukie Nakai,Tomomi Ida,Ayaka Mizumoto,Yoshihiro Yamamoto,Tomoki Saito,Shigeki Kataoka,Junichi Matsubara,Atsushi Yamada,Masashi Kanai,Shigemi Matsumoto,Hiroaki Sakai,Kiyotsugu Yoshikawa,Eijiro Nakamura,Manabu Muto.

HER2 G776S Mutation Promotes Oncogenic Potential in Colorectal Cancer Cells when Accompanied by Loss of APC Function.

Sci Rep. 2022 Jun 2;12(1):9213.

Akari Minamoto,Takahiro Yamada,Saki Shimada,Ichiro Kinoshita,Yoko Aoki,Katsutoshi Oda,Arisa Ueki,Satomi Higashigawa,Maki Morikawa,Yuki Sato,Akira Hirasawa,Masanobu Ogawa,Tomohiro Kondo,Masahiro Yoshioka,Masashi Kanai,Manabu Muto,Shinji Kosugi.

Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire survey.

J Hum Genet. 2022 Oct;67(10):557-563.